INTRODUCTION
The etiology of most childhood leukemias remains unknown, but exposure to moderate and high levels of ionizing radiation is an established risk factor. Risk models based on the Japanese atomic bomb survivors imply that low-level exposure to radiation appreciably increases the risk of childhood leukemia (1, 2) . Natural background radiation accounts for the greatest radiation exposure of the average member of the Great Britain (i.e. England, Wales and Scotland) population, and this has prompted interest in a possible link between radiation from natural sources and childhood leukemia. For example, in Great Britain the mean annual effective dose from terrestrial c and cosmogenic radiation is estimated to be 0.68 mSv (3) , and in the U.S. this figure is only slightly lower at 0.54 mSv (4). Wakeford et al. (5) showed that using risk models based on the latest Japanese atomic bomb survivor data (1, 2) about one-fifth of the cases of childhood leukemia in Great Britain might be attributable to natural background radiation, raising the possibility that such excess risk may be detectable in an epidemiological study.
Epidemiological studies investigating the role of natural background radiation in the etiology of childhood leukemia have been undertaken (2) . Some studies [e.g. refs. (6, 7) ] have reported a positive association between exposure to naturally occurring radon and childhood leukemia, but in Great Britain, various large studies (8) (9) (10) (11) did not provide convincing evidence of a positive association with either background c radiation or radon. The purpose of this paper is to explore what may be the main reason for the failure to detect an effect--a lack of statistical power consequent on an insufficient number of cases. Other possible reasons are also considered in the Discussion.
In this paper we derive formulae for statistical power based on score tests for cohort, geographical correlation (''ecological'') and case-control study designs somewhat similar to those considered by Lubin and Gail (12) , differing principally in that we assume a conditional likelihood and a linear relative risk, or odds ratio, function of exposure. We demonstrate that heterogeneity in the excess relative risk has minimal effect on the statistical power and estimate the statistical power required to investigate realistically the relationship between childhood leukemia and natural background radiation. We consider both individual-based cohort studies and geographical correlation studies based on incidence and exposure averaged over areal units; formally, these two types of study are identical, but as we show, the power of ecological studies is somewhat less than cohort studies because of the narrower dose distribution.
MATERIALS AND METHODS

Doses to Red Bone Marrow
The main sources of exposure to natural background radiation are terrestrial c rays, cosmic rays, radionuclides in food, and isotopes of the radioactive gas radon (13) . The components of red bone marrow (RBM) dose that can be estimated on an individual basis in epidemiological studies account for about half the total such dose from natural radiation sources (Table A1) . In epidemiological studies, measurements of c rays will generally have included the directly ionizing component of cosmic rays, and in this paper we use the term ''gamma'' in this sense. A Great Britain National Survey (3, 14) provided evidence of indoor exposures to (a) terrestrial c rays plus the directly ionizing component of cosmic rays and (b) radon-222. Using methods described by Kendall et al. (15) , these measurements were converted to annual doses to RBM and used to estimate deciles of the distribution of RBM dose from these components, separately or jointly (Tables A2, A3 ). We also derive the deciles of exposure distribution for English county districts and comparable administrative divisions elsewhere in Great Britain. These typically contain a population of about 100,000, so that the variability of mean dose rates will be somewhat less than for individuals (Tables A2, A3 ).
Data on Childhood Leukemia
Annual numbers of registered incident cases of childhood leukemia by sex and year of age, diagnosed during 1991-2000 while resident in Great Britain, and the derived incidence rates were obtained from the National Registry of Childhood Tumours (Table A4 ). This registry is thought to be substantially complete (16, 17) . All simulations are conditional on a given number of cases in each stratum (which is generally determined by age), as given by the age distribution implicit in Table A4 .
Statistical Methods
The methods used to calculate statistical power are given in Appendix B. Table 1 presents results for cohort, Great Britain county districtbased ecological and case-control studies, showing the percentage of normalized score simulations that are greater than the various assumed nominal values given in the leftmost column. These were calculated using the deciles of dose distribution given in Appendix A. To assess the distribution of the score statistic, 100,000 simulations from the assumed distribution are used. From Eqs. (B4) and (B5) in Appendix B, the normalized score assuming a single stratum with 10 years of UK cases can be shown to have mean 2.325. Since this has variance 1 the Monte Carlo error for N samples will be 1= ffiffiffiffi ffi N p , which for N~100,000 is 0.0032, which we judge to be acceptably small. We assume a standard 2-year minimum latent period for leukemia (1, 2, 18, 19) . For simplicity we employ the BEIR V leukemia risk model throughout, which is a pure excess relative risk (ERR) model (18) . The more recent BEIR VII leukemia model (1) is a combination of additive and multiplicative models and is less attractive for evaluating power in a case-control study, in which we make use of the near equivalence of odds ratio and relative risk. Since we are only concerned with expression of leukemia risk in childhood and since both models are based on the Japanese atomic bomb survivor mortality data (20, 21) , there should be minimal difference between them, driven mainly by the change in dosimetry system from DS86 to DS02 (21) . The BEIR V leukemia excess relative risk (ERR) model (18) assumes a linear-quadratic dose response, so that the leukemia risk in childhood in group i with underlying leukemia risk p i and dose D i is given by p i ½1zh½1zbD i D i . At low doses the doseresponse curve is approximately linear with a slope (on the relative risk scale) of h~ERR~32:1 Sv {1 . In Fig. 1 we also assess the power for a population with heterogeneous risk. For illustrative purposes, we assume, somewhat (22) . Therefore, the ''average'' ERR is approximately the same as that of BEIR V, but with a substantial fraction having an ERR that is smaller or larger, reflecting an appreciable variation in the background risk of leukemia within the cohort.
The BEIR V leukemia risk model applies only to radiation doses received after birth and not to doses received in utero. To accommodate risk from exposure in utero, we assume that the intrauterine dose generates an excess risk throughout childhood with the same ERR coefficient. There is evidence that diagnostic X-ray exposure in utero induces a leukemia risk that is compatible with that produced by exposure in early childhood (23, 24) , although this evidence remains controversial (25) , with some maintaining that there is no evidence of excess risk associated with in utero exposure (26) . In Table 2 we explore the sensitivity of results to this assumption using calculations in which the in utero dose has no effect on leukemia incidence; the table shows the percentage of normalized score simulations that are greater than the various assumed nominal values given in the leftmost column. We also explore the effect of assuming that only radon or c radiation contributes to the induction of leukemia.
We use separate strata for each calendar year of age and sex. Table 1 shows that with a 10-year (or 20-year) followup of all childhood leukemias in Great Britain, after which there are 4576 (or 9152) registrations, there is a 67.9% (or 90.9%) chance of detecting an excess score at the one-sided 5% significance level for an individualbased cohort study, 57.9% (or 83.2%) for an area-based (county district) design, and 61.1% (or 86.0%) for a casecontrol study with five controls per case. Case-control studies with five controls per case achieve much of the statistical power of a cohort design (and are more powerful than area-based designs), 61.1% (or 86.0%), although the power is reduced with only a single control per case, 44.3% (or 68.4%) ( Table 1 , Fig. 1 ). There is minimal improvement in power for more than five controls per case (Fig. 2) ; e.g., with 10 and 20 controls per case the power with 20 years of follow-up is 88.6% and 89.9%, respectively. Figure 1 shows that the effects of heterogeneity in risk serve to slightly degrade the , and for a case-control study (with one or five controls per case) with the same (homogenous) EOR. The power illustrated is to detect a statistically significant (onesided P 5 0.05) increasing trend of risk with dose, assuming distributions for RBM doses as in Table A2 , and case distribution per year in Great Britain as in Table A4 . Another way of considering this issue is to examine the year of follow-up when 80% power is achieved. Figures 1  and 2 show that with 1, 2, 5, 10 and 20 controls per case, 80% power (for a one-sided 5% test) is achieved with approximately 28, 21, 17, 16 and 15 years of follow-up respectively; these times correspond to studies that include <12,800, 9600, 7800, 7300 and 6900 cases, respectively. Likewise, an individual-based cohort study achieves 80% power with 14 years of follow-up, with about 6400 cases, whereas an area-based design only achieves this power with 19 years of follow-up and 8700 cases.
RESULTS
Similar power is achieved if only c radiation is assumed to contribute to leukemia risk, with 50.9% power at 10 years and 76.2% at 20 years of follow-up for a case-control study with five controls per case; for radon alone the power is much less, 25.0% at 10 years and 39.2% at 20 years of follow-up ( Table 2 ). Omission of in utero dose only minimally affects statistical power, resulting in 56.8% power at 10 years and 82.2% at 20 years of follow-up (Table 2) .
Power is markedly affected by the assumed level of risk. As can be seen from Fig. 3 , if the BEIR V ERR coefficient is increased by a factor of 2 (or 4), then with a single control per case 80% power is achieved (for a onesided 5% test) within 10 (or 5) years of follow-up [corresponding to about 4580 (or 2290) cases], and with five controls per case within 6 (or 3) years of follow-up [corresponding to about 2750 (or 1370) cases]. Conversely, if the ERR is decreased by a factor of 2 (or 4) then even after 40 years of follow-up (corresponding to about 18,300 cases) the statistical power is only 50.6% (or 22.2%) with a single control per case, and 68.5% (or 30.0%) with five controls per case.
DISCUSSION
In this paper we have assessed the practical effect on the statistical power of differences in design for studies of childhood leukemia and exposure to natural background ionizing radiation. We have also demonstrated that even under fairly extreme heterogeneity in excess relative risk, little difference is made to the statistical power ( Fig. 1) . Case-control studies with five controls per case achieve much of the power of an individualbased cohort design and are more powerful than geographical correlation studies (Fig. 2) . The minimal gain in power with more than five controls per case is known in other contexts (27, 28) . With one or five controls per case, it is estimated that to achieve 80% power for a one-sided 5% test would require 28 or 17 years of childhood leukemia cases in Great Britain, respectively. The childhood population in Great Britain over the period 1991-2000 averaged about 9.3 million, which implies that of the order of 130 million personyears of follow-up would be required for an individualbased cohort study to have 80% power.
Calculations based on the case numbers occurring within the catchment area of the 17 registries included in the U.S. Surveillance, Epidemiology and End Results (SEER) program (29) and the likely U.S. (terrestrial c and cosmogenic radiation) dose distribution (4) suggest, apparently paradoxically, that there is only slightly more power available per year of follow-up in the U.S. than in Great Britain. Although the 17 SEER registries have about twice the number of childhood leukemia cases per year compared with Great Britain, the mean dose (for the U.S. as a whole) is somewhat less; for example, the UK mean annual effective dose from terrestrial c and cosmogenic radiation is estimated to be 0. In epidemiological studies there may be differences between exposed and unexposed groups in some unmeasured factor(s) that affect the risk of childhood leukemia and that may be correlated with exposure, i.e. confounding. For a high-exposure study with a large expected effect, such variations are fairly inconsequential. However, for a low-exposure study with small expected effect, the magnitude of such confounding may well obscure the expected radiation effect. Assessment of the pattern of results in low-exposure studies may sometimes provide indications of artifactual findings. For example, Puskin , distribution for RBM dose as in Table A2 , and a case distribution per year in Great Britain as in Table A4 .
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LITTLE ET AL. (30) , in an ecological study, investigated cancer mortality and estimates of mean radon exposure in U.S. counties and showed that smoking-related cancers exhibited strongly negative correlations with radon daughter exposure, while non-smoking-related cancer was uncorrelated, suggesting that smoking confounds the radon dose response for some smoking-related cancers. Various methods have been proposed for assessing the possible effects of such unmeasured confounding factors (31, 32) . Unmeasured confounding variables may play a role in the negative findings in some previous studies of leukemia and natural background radiation (8) (9) (10) . Confounding factors, in particular lifestyle factors, can be addressed most easily in case-control studies, since few population registries ascertain this type of information. There are not many known substantial risk factors for childhood leukemia apart from ionizing radiation (unlike many cancers in adulthood), so that at least for this end point it is not so important to adjust for such variables, although confounding by unknown major risk factors must remain a possibility.
The United Kingdom Childhood Cancer Study (UKCCS), which included radiation measurements on about 2200 cases of childhood cancer of all types (of which about a third are leukemia) and around twice as many controls (9, 10) has, by the results of our paper, little power to detect trends with dose; our calculations suggest that it would require at least 9600 leukemia cases to have 80% power of detecting a positive trend at the one-sided 5% level.
Case-control studies may be affected by participation bias when individual measurements of radiation exposure are required. For example, 87% of cases of childhood cancer eligible for inclusion in the UKCCS were interviewed but only 64% of eligible controls (9).
Radon measurements were then made in the homes of 58% of interviewed cases but only 49% of interviewed controls (9) . Thus radon measurements were actually made in the homes of 50% of eligible cases but only 31% of eligible controls, leaving considerable scope for bias. Moreover, the UKCCS found strong and socioeconomic-related participation bias with, for example, the noninterviewed first-choice controls showing a skew toward the more deprived groups, with 25% of those refusing to be interviewed coming from the most deprived seventh (where 15% would be expected) (33) . The participation bias that potentially affects the UKCCS (9) and other case-control studies could affect cohort studies equally. For this reason register-based studies, in particular those that make use of model-based predicted doses that avoid the need for measurements in individual homes, have considerable advantages. For example, the Danish casecontrol study of radon exposure and childhood leukemia of Raaschou-Nielsen et al. (7) estimated individual doses from radon using national registry data on house and soil type and a model based upon a previous program of radon measurements. In principle, a similar algorithm for predicting c-ray (and cosmic-ray) dose rates in houses could be developed, or map data could be used.
The area-based study of Richardson et al. (8) , with 6691 cases of childhood leukemia, is also somewhat underpowered according to the above calculations-8700 cases are required for 80% power. As a geographical correlation study it is free of the participation bias that apparently affected the UKCCS. However, such studies are vulnerable to bias and confounding, such as that resulting from unmeasured (within area) correlations between risk factors and radiation dose (34, 35) Table A2 , and a case distribution per year in Great Britain as in Table A4 .
LEUKEMIA, BACKGROUND RADIATION AND STATISTICAL POWER this bias occurred in ecological studies of radon and lung cancer, where statistically significant negative correlations are observed (36, 37) .
The Danish case-control study of radon exposure and childhood leukemia of Raaschou-Nielsen et al. (7), with only 1503 leukemia cases and 2306 controls, appears to be underpowered. Assuming an age-sex distribution of cases as in Great Britain and that radon doses are two to three times those in Great Britain (7) implies that the study should have power for a one-sided 5% test in the range 21-33%. Cases and controls were drawn from national registries (which contained residential history), so participation bias was avoided. The radon exposures were estimated using a model based on geographical region, soil type and house characteristics, which again avoided potential participation bias. Raaschou-Nielsen et al. reported that cumulative radon exposure was associated with risk for acute lymphoblastic leukemia, with a magnitude greater than would be expected from conventional risk estimates, but not for other types of childhood cancers. The errors associated with the radon concentration predictions were thought to be largely Berksonian (38) , so that appreciable bias in the trend estimate would not be expected, but since the model was developed empirically, the use of estimated parameters can introduce classical error, which can induce bias in the regression. For an underpowered study, if any risk estimate is statistically significant, its magnitude is in all likelihood a substantial overestimate of the ''true'' risk (39) . This may partially explain the apparently strong trend with radon exposure in the Danish study (7), although it is likely that once statistical uncertainties are taken into account the association is compatible with the predictions of conventional risk models. The strengths of this type of record-based case-control study (potentially large numbers of cases and freedom from participation bias) would in principle also apply to an analogous study of c rays. However, the use of estimated doses rather than those measured directly in the homes in question will inevitably lead to increased uncertainty. Uncertainty in dose estimates is not taken into account in our calculations, but its impact in assessing trends of dose response is likely to be substantial. In general the effect of uncertainties in dose is to widen confidence intervals for regression parameters and thereby lower the power of a study (40) . It is implicit in the form of risk models used and the preponderance of cases under the age of 5 years that doses in early life are much more important than doses later in childhood. For this reason it is less important to know the place of residence at the time of diagnosis than the place of birth. This is a critical consideration for ecological studies, and it implies that these should be organized in terms of area of birth rather than area of diagnosis of the case. Migration is another issue that would affect ecological studies if analyzed in terms of residence at time of diagnosis rather than at birth, and because people move house on average every 5 to 7 years it would be expected to appreciably dilute the observed risk.
For simplicity the BEIR V leukemia risk model has been used, for the reasons stated in the Methods section. This model expresses the radiation-induced risk purely in terms of the ERR of leukemia. As discussed by Wakeford et al. (5), a significant source of uncertainty in the estimation of the childhood leukemia risk arises from the assumption of the nature of the transfer of the radiation-induced risk between populations when the baseline risk of childhood leukemia differs, as it does between the Japanese atomic bomb survivors and British children in the late 20th century-the rate of incidence of childhood leukemia in Great Britain during the 1990s was ,2K times greater than that in Japan during the 1950s. Transfer of the Japanese atomic bomb survivors ERR, which is implicit in the BEIR V risk model, leads to a greater predicted number of radiation-induced cases of leukemia among British children than if the excess absolute risk (EAR), or some mixture of the ERR and EAR, is transferred. Wakeford et al. (5) argued that transfer of the ERR, or of the 70% ERR/30% EAR mixture adopted by the BEIR VII Committee, is better supported by the epidemiological evidence, but that this evidence is limited (22) . Transfer of EAR to a Great Britain population would be approximately equivalent to use of the BEIR V model with the risk coefficient reduced by a factor of ,2K, and the results of Fig. 3 imply that in this case 80% power would not be achieved even with 40 years of follow-up when using five controls per case. The BEIR V leukemia model (18) does not assume any variation in relative risk for those exposed in childhood up to 15 years after exposure. More recent risk models would certainly predict such variation (1, 2), but it is unlikely that such variation of risk over this period would much affect the calculations presented here.
Our main results are for studies in which doses from c rays and radon have been combined. In principle, this approach provides higher and more variable doses which should result in improved power, but at the cost of becoming dependent on the reliability of the calculated doses. However, our results indicate that little improvement is obtained by combining c-ray and radon doses over c rays alone. This suggests that the simpler approach, of considering the components separately, is to be preferred. It is highly probable that the risks from c rays and from radon are proportional to the measured quantity (dose rate and radon concentration, respectively) and that the analysis can be carried out in terms of these quantities, as has usually been done.
Studies of childhood leukemia and c rays have greater power than studies of radon of a similar size. The preponderance of studies of radon and childhood leukemia in the literature may be a consequence of the greater availability of detailed data on radon exposures compared 392 to c rays and possibly also to the positive findings of studies of residential radon exposure and lung cancer.
We emphasize studies of childhood leukemia in relation to natural background radiation exposure in part because of the elevated radiosensitivity of this end point at this age; this results in such studies having generally greater statistical power than similar studies of cancer in adulthood. ''Childhood'' is usually taken to refer to disease diagnosed at the ages 0-14 years. For example, this age range is the basis of case ascertainment employed by the UK National Registry of Childhood Tumours (NRCT) (41) , UKCCS (9) and the Childhood Leukemia International Consortium (CLIC) (42); however, a larger age range, up to at least age 18 years, is used in the International Childhood Cancer Cohort Consortium (I4C) (43) . There is some degree of arbitrariness in the precise age range to be used, and the issue of latency clearly complicates what should be the natural age range to consider.
The UK NRCT (41) has virtually complete ascertainment of cases of childhood cancer in Great Britain over the last several decades. These data together with matched controls selected from national birth registers and doses estimated from national radon and c-ray maps could provide the basis for a study similar to that of RaaschouNielsen et al. (7), and indeed such a study is under way. In principle, a similar study might be undertaken with other large databases, in particular the CLIC and I4C studies (42, 43) . The focus of the present paper is largely methodological, and the U.S. and Great Britain are used illustratively mainly because of the good quality national cancer registers there. Nevertheless, studies could be undertaken in many other developed countries and are most likely to be informative in areas with good quality cancer registries and having particularly high (and variable) natural background radiation exposure.
CONCLUSIONS
In summary, for a Great Britain population, the number of years of accumulated childhood leukemia cases to achieve 80% power for a one-sided 5% test would be:
For a cohort study: 14 years (6400 cases) For a case/control study (5 controls per case) : 17 years (7800 cases) For a case/control study (1 control per case) : 28 years (12800 cases) For an ecological study: 19 years (8700 cases) These estimates assume that doses from radon and c rays (including the directly ionizing component of cosmic rays) are combined. For studies using c rays alone, the required numbers of cases would be somewhat larger and for radon alone much larger. In addition, participation bias may seriously affect studies that require individual consent, while geographical correlation studies suffer from severe interpretational problems. We argue that most previous studies have been underpowered and that most were subject to unquantifiable biases and confounding. Experience suggests that studies requiring individual consent are subject to (possibly large) participation bias and are likely to be extremely expensive if an adequate number of cases is to be included. Record-based studies avoid these problems, though they are not entirely free of difficulty (e.g., in that doses have to be estimated rather than measured). Nonetheless, our results show that large studies should be capable of detecting the predicted risk of childhood leukemia from natural background radiation and potentially provide important evidence on the risk of childhood leukemia after low-level irradiation, a subject that continues to be debated. 230  290  330  360  380  410  430  460  500  580  1  440  560  630  680  730  770  810  870  940  1190  5  420  540  610  660  700  740  790  840  910  1160  10  400  510  580  620  670  700  740  790  860  1100  15  370  470  530  570  610  640  680  720  780  1020  Adult  360  450  510  550  590  620  660  700  760 220  290  320  350  370  400  420  450  490  560  1  380  500  570  620  660  700  740  790  860  990  5  370  490  550  590  630  680  720  770  830  960  10  350  460  510  560  600  640  670  720  780  900  15  310  410  460  500  540  570  610  650  700  810  Adult  300  400  450  490  520  550  590  630  680  780  Radon  In utero  0  0  0  1 0  1 0  1 0  1 0  1 0  2 0  5 0  All postnatal ages  20  30  30  40  40  50  70  80  110  330  County districts  Terrestrial c radiation  In utero  250  310  330  350  370  390  410  430  450  500  1  450  540  590  620  650  690  730  760  800  890  5  430  520  560  600  630  660  700  730  770  860  10  400  490  530  560  590  620  660  690  730  810  15  370  440  480  510  530  560  590  620  650  730  Adult  340  420  450  480  500  530  560  590  620  690  Radon  In utero  0  0  10  10  10  10  10  10  20  50  All postnatal ages  30  40  40  50  60  60  70  90  120  400 394 
APPENDIX B
Derivation of Formula for Score Tests for Cohort Studies and Case-Control Studies
Cohort Study
The score test (44) is a commonly used method for assessing trends of risk with dose. In particular, it has been used in this way in assessing trends of cancer risk with dose in various occupational studies (45) (46) (47) . This Appendix outlines its use for this purpose and how it can be used to assess statistical power. The score is the derivative of the log-likelihood with respect to the dose trend parameter. In particular, if a relative risk model is assumed in which the cancer risk (whether for incidence or mortality) in cell j of stratum i is given by p ij : ½1zh i : D ij , then the log (multinomial) likelihood is given by
where M i is the total number of cancer cases or deaths in stratum i, m ij is the observed number of cancer cases or deaths in cell j of stratum i (so that P Ki j~1 m ij~Mi ), and p ij is the proportion of the population (e.g. proportion of person years of observation) of cell j making up stratum i (so
(This is the likelihood obtained by conditioning on the total number, M i , of cases in each stratum i.)
If we assume that h
so that at h~0 this reduces to
LEUKEMIA, BACKGROUND RADIATION AND STATISTICAL POWER Therefore, 
It should be noted that this last expression is not the same as var h~0 dL dh
! . Note also that this calculation includes the covariance terms induced by the correlations between the multinomial terms in the likelihood.
Therefore, the normalized score, given by Z~d L dh 
If this is to equal p, then
Therefore, it must be that N 1{a {Z 0~N1{p , or equivalently that
Considering a single stratum, with M 1~M , K 1~K etc., then by Eqs. (B1) and (B2), for the cohort to have power p it must be that
For small h and D i this varies approximately as the inverse of the square of the average dose and as the inverse of the square of the expected ERR per Sv, h. Figure 1 and Table 1 illustrate these formulae with calculations of Monte Carlo simulations of power for a cohort having the natural background dose distribution for the Great Britain population, as described in Appendix A. Tables A2 and A3 give the dose distributions assumed. The Monte Carlo simulations are performed by sampling within each stratum the number of cases m ij from the multinomial distribution with probabilities
The normalized score statistic for simulation s, dL dh
h~0
, for this simulated set of cases is then estimated using formula (B3) and the normalized
, then derived using this and formula (B5).
Case-Control Study
We assume that there are S cases and that for case i there are K i controls. n d1i~1 ) the retrospective likelihood is given by
This is maximized in
so that the profile log-likelihood becomes
Therefore, the score statistic is
In particular, if we assume that the odds ratio has the form l d (h)~1zhD d , so that h is the excess odds ratio (EOR) per Sv, then LEUKEMIA, BACKGROUND RADIATION AND STATISTICAL POWER dL dh
Therefore, 
Assuming that p d0i :p d0 , K i :K then these reduce to
and 
For small h and D i this varies approximately proportionally to the average dose, and as the square root of the number of cases or deaths, S. As above, for the score statistic to have power 100p% to detect an excess with type I error a it must be that Z 0~N1{a {N 1{p . This implies that Tables 1 and 2 illustrate these formulae with calculations of Monte Carlo simulations of power for a case-control study drawn from a population having the natural background dose distribution for the Great Britain population, as described in Appendix A. Tables A2 and A3 give the dose distributions assumed. The Monte Carlo simulations are performed by sampling within each stratum i the indicator for the case n d1i in each case-control set from the multinomial distribution with probabilities 
The normalized score statistic for simulation s, dL dh h~0 , for this simulated set of cases is then estimated using formula (B16) and the normalized score, Z~d L dh h~0 , var h dL dh h~0 ! 0:5 , then derived using this and formula (B180).
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